Ascentage Pharma Group International (NASDAQ:AAPG) Upgraded to “Strong-Buy” at Citigroup

Citigroup upgraded shares of Ascentage Pharma Group International (NASDAQ:AAPG) to a strong-buy rating in a research report report published on Wednesday morning,Zacks reports.

A number of other brokerages also recently issued reports on AAPG. JPMorgan Chase & Co. lowered their price target on shares of Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating on the stock in a report on Thursday, October 8th. William Blair initiated coverage on shares of Ascentage Pharma Group International in a research note on Friday. They set an “outperform” rating for the company. Citizens Jmp started coverage on shares of Ascentage Pharma Group International in a report on Tuesday. They set a “market outperform” rating and a $35.00 target price on the stock. Finally, BTIG Research reiterated a “buy” rating and issued a $48.00 target price on shares of Ascentage Pharma Group International in a research note on Friday, August 21st. Three analysts have rated the stock with a Strong Buy rating and eleven have given a Buy rating to the company. Based on data from MarketBeat, Ascentage Pharma Group International has a consensus rating of “Buy” and a consensus price target of $43.90.

Ascentage Pharma Group International Trading Down 1.1%

AAPG opened at $14.69 on Wednesday. The firm has a 50-day moving average price of $16.55 and a 200-day moving average price of $19.11. Ascentage Pharma Group International has a twelve month low of $14.45 and a twelve month high of $37.50. The company has a current ratio of 1.22, a quick ratio of 1.18 and a debt-to-equity ratio of 1.09.

Ascentage Pharma Group International (NASDAQ:AAPG) last issued its earnings results on Wednesday, August 19th. The company reported ($0.65) earnings per share (EPS) for the quarter. The business had revenue of $22.24 million for the quarter. As a group, analysts predict that Ascentage Pharma Group International will post -2.42 EPS for the current year.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.